Laurel Wealth Advisors (California)’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
CIP
Laurel Wealth Advisors (California)'s GMED Position: Q4 2022 in Review
Laurel Wealth Advisors (California) reduced its Globus Medical (GMED) stake by 10% in Q4 2022, selling an estimated $121K and leaving 15,343 shares worth $1.14M. The position accounts for 0.11% of the portfolio, ranked #191.
Laurel Wealth Advisors (California) first reported a position in GMED in Q4 2021 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold GMED as of Q4 2022.
- Laurel Wealth Advisors (California) held 15,343 shares of Globus Medical worth $1.14M as of Q4 2022.
- Laurel Wealth Advisors (California) sold 1,780 Globus Medical shares in Q4 2022, an estimated $121K.
- Globus Medical made up 0.11% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #191 holding.
- Laurel Wealth Advisors (California) first reported a position in Globus Medical in Q4 2021 and has held it in 5 quarters since.
- 390 funds tracked by Wall St. Rank held Globus Medical as of Q4 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.